LEHI, Utah, March 11, 2025 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for chronic inflammation and obesity-related diseases ...
Halia Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for chronic inflammation and obesity-related diseases, announced that it has been awarded the Novo Nordisk ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback